Condition: Pneumonia, Ventilator-Associated · Sponsor: Region Skane
The purpose of this study is to evaluate different peptide biomarkers, variations in the microbiome and patterns in the bacterial transcriptome as prognostic or diagnostic biomarkers of VAP.
This description comes directly from the study's public registry record.
Magnus Paulsson, PhD MD · +46461775431 · magnus.paulsson@med.lu.se
Always discuss trial participation with your own doctor first.
| Vestre Viken | Drammen, Norway | Recruiting |
| Hospital de São Francisco Xavier | Lisbon, Portugal | Recruiting |
| Skåne University Hospital, Dept. of Infectious diseases | Lund, Sweden | Recruiting |
| Skåne university Hospital, ICU | Malmö, Sweden | Recruiting |
| Karolinska University Hospital, ICU | Solna, Sweden | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05117125